The 3 best performing ASX shares in the week of 7 November 2022
Marc Kennis, November 14, 2022
The 3 best performing ASX shares in the week of 7 November 2022
The 3 best performing ASX shares of the week starting 7 November 2022 were Invictus Energy (ASX:IVZ), up 108.7%, Aeris Resources (ASX:AIS), up 57.8%, and Novatti Group (ASX:NOV), up 43.2%.
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
1. Invictus Energy (ASX:IVZ)
Industry: Energy
Invictus Energy (ASX:IVZ) is an independent upstream oil and gas company. The company is opening rift basins in onshore Africa – the Cabora Bassa Basin – in northern Zimbabwe through a high impact exploration program.
Market Cap: $210m
12 month high / low: $0.10 – $0.36
2. Aeris Resources (ASX:AIS)
Industry: Resources
Aeris Resources (ASX:AIS) is a diversified mining and exploration company listed on the Australian Securities Exchange and headquartered in Brisbane, Queensland. During the year the company is involved in production and sale of copper, gold and silver and the exploration for copper and gold.
Market Cap: $349m
12 month high / low: $0.275 – $1.20

3. Novatti Group (ASX:NOV)
Industry: Industrials
Novatti Group (ASX:NOV) rounds out our 3 best performing ASX shares this week. NOV is a payment processing platform that facilitates mobile and alternative financial payments solutions and services.
Market Cap: $92m
12 month high / low: $0.15 – $0.43

No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
No credit card needed and the trial expires automatically.

Blog Categories
Get Our Top 5 ASX Stocks for FY26
Recent Posts
Imricor Medical (ASX:IMR) FDA Approval Ignites Shares, but the Real Test Starts Now
FDA Approval Is a Big Win, Not the Finish Line Imricor Medical (ASX:IMR) received FDA clearance for its Vision-MR diagnostic…
How Nuclear Energy Became the World’s Most Feared Energy Source
Why Nuclear Energy Still Scares Us and What Really Went Wrong Many investors may remember periods when nuclear energy captured…
Dateline Resources (ASX:DTR) From 60c Highs to Hard Lessons
A Rare Earth Story the Market Loved Then Questioned For investors who have followed Dateline Resources (ASX:DTR), the past year…